| 2023-12-27 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 30,000 0.0237% | $195.00 | $5.85M | -22.46% | |
| 2023-08-03 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 6,448 0.005% | $185.38 | $1.2M | -13.11% | |
| 2019-12-04 | Bristol-Myers Squibb Company BMY | director | 176 <0.0001% | $58.90 | $10,366 | +5.24% | ||
| 2019-09-09 | Sarepta Therapeutics, Inc. SRPT | director | 2,000 0.0027% | $86.74 | $173,480 | +39.82% | ||
| 2016-03-09 | Alnylam Pharmaceuticals, Inc. ALNY | director | 4,000 0.0046% | $58.36 | $233,440 | -4.87% | ||
| 2015-05-12 | Alnylam Pharmaceuticals, Inc. ALNY | director | 4,000 0.0047% | $112.16 | $448,640 | -19.19% |